Gates Medical Research Institute and SII Reach Agreement for the Manufacture of M72/AS01E Tuberculosis Vaccine Candidate, Pending Successful Phase 3 Outcomes...Read more
World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group...Read more
Brazil, Malaysia and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India...Read more
